(Q41604423)

4 October 2017

1 reference

title

The in vivo anabolic actions of prostaglandins in bone (English)

1 reference

4 October 2017

Jee WS

1

1 reference

PubMed ID

9315332

4 October 2017

Ma YF

series ordinal

2

1 reference

4 October 2017

1 October 1997

1 reference

4 October 2017

1 reference

4 October 2017

21

1 reference

4 October 2017

297-304

1 reference

4 October 2017

4

1 reference

Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Intermittent treatment of prostaglandin E2 with risedronate is more anabolic than prostaglandin E2 alone in the proximal tibial metaphysis of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Skeletal alterations in hypophysectomized rats: II. A histomorphometric study on tibial cortical bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Mechanical loading and sex hormone interactions in organ cultures of rat ulna.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's law: the bone modeling problem

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's law: the remodeling problem

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

The role of changes in mechanical usage set points in the pathogenesis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Perspectives: on a "paradigm shift" developing in skeletal science.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: a histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 prevents disuse-induced cortical bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Extra cancellous bone induced by combined prostaglandin E2 and risedronate administration is maintained after their withdrawal in older female rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Maintenance therapy for added bone mass or how to keep the profit after withdrawal of therapy of osteopenia

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Greater bone formation induction occurred in aged than young cancellous bone sites.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Partial loss of anabolic effect of prostaglandin E2 on bone after its withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 restores cancellous bone to immobilized limb and adds bone to overloaded limb in right hindlimb immobilization rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Risedronate plus prostaglandin E2 is superior to prostaglandin E2 alone in maintaining the added bone after withdrawal in a non-growing bone site in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Co-treatment of PGE2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Alveolar bone augmentation following the local administration of prostaglandin E1 by controlled-release pellets

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Local stimulation of new bone formation by prostaglandin E1: quantitative histomorphometry and comparison of delivery by minipumps and controlled-release pellets

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

The role of prostaglandins in bone in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Systemic effects of prostaglandin E2 on vertebral trabecular remodeling in beagles used in a healing study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

The origin of bone cells in the postnatal organism

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Mechanical loading stimulates rapid changes in periosteal gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

High bone turnover is associated with low bone mass in both pre- and postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Exogenous prostacyclin, but not prostaglandin E2, produces similar responses in both G6PD activity and RNA production as mechanical loading, and increases IGF-II release, in adult cancellous bone in culture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Effect of prostaglandin E1 on regional haversian remodeling in beagles with fractured ribs: a histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Bone remodelling induced by physical stress is prostaglandin E2 mediated

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Prostaglandin E2 increases the skeletal response to mechanical loading

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Systemic administration of an anabolic dose of prostaglandin E2 induces early-response genes in rat bones

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Intraosseous infusion of prostaglandin E2 in the caprine tibia

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure-activity relations and signal transduction pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Increased bone growth by local prostaglandin E2 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Tensile forces enhance prostaglandin E synthesis in osteoblastic cells grown on collagen ribbons

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Growth hormone administration potentiates the effect of treadmill exercise on long bone formation but not on the vertebrae in middle-aged rats

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

Early responses to dynamic strain change and prostaglandins in bone-derived cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2897%2900147-6

7 January 2021

10.1016/S8756-3282(97)00147-6

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9315332